Terms ending in 2029
Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,183,241 | 2-OXO-1-Pyrrolidine Derivatives In force · Medium confidence | Ucb Biopharma SRL | In force | Medium confidence | |
| US 8,242,116 | Fused Thiazole Derivatives as Kinase Inhibitors In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 8,293,237 | Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 8,501,723 | Pharmaceutical Compositions Comprising Fesoterodine In force · Medium confidence | Ucb Pharma GmbH | In force | Medium confidence | |
| US 8,075,889 | Antibody Molecules Having Specificity for Human IL-6 In force · High confidence | R-Pharm International LLC | In force | High confidence | |
| US D724,203 | Drive Device for Administering Medication In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US D726,901 | Drive Device for Administering Medication In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US D726,902 | Cassette Device for Administering Medication In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 8,679,494 | Antibodies Specific to IL-17A and IL-17F In force · Medium confidence | Ucb Biopharma SPRL | In force | Medium confidence | |
| US 9,771,420 | Methods of Treating an IL-17A Mediated Pathological Condition In force · Medium confidence | Ucb Biopharma SPRL | In force | Medium confidence | |
| 6 more term ends in 2029 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
2 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.